ConCallIQ
Go Pro
EP
EPL Other 10 Feb 2026

EPL Limited — Q3 FY26

EPL delivered another strong quarter with 13.3% revenue growth, driven by broad-based double-digit expansion across three of four regions.

bullish high
Revenue ₹1,149 Cr +13.3%
EBITDA +12%
PAT ₹83 Cr
EBITDA Margin 20.1% -20bps
Duration 50 min

✓ Verified against BSE filing

2-Min Summary

EPL delivered another strong quarter with 13.3% revenue growth, driven by broad-based double-digit expansion across three of four regions. The beauty & cosmetics segment continued to outperform, growing 26% YoY and now representing 53% of the portfolio. EBITDA margin held at 20.1%, within the target range, though down 20bps YoY due to Europe operational issues. PAT was flat due to a one-off base effect; excluding that, PAT grew 11%. ROCE improved 184bps to 18.7%. Management reiterated its long-term guidance of sustained double-digit revenue growth with EBITDA growth slightly ahead. Key risks include Europe margin recovery timing and potential commodity price volatility, though pass-through mechanisms have been strengthened.

Key Numbers

Beauty & Cosmetics Growth 26%
+26% YoY

Beauty & cosmetics segment grew 26% YoY, outperforming overall growth and driving portfolio mix shift.

Non-Oral Share of Portfolio 53%
+?pp YoY

Non-oral (primarily beauty & cosmetics) now accounts for 53% of total portfolio, up from prior periods.

Sustainable Tube Sales Share 38%
flat YoY

Sustainable tube formats contributed 38% of sales, reflecting sustained customer adoption.

ROCE 18.7%
+184bps YoY

ROCE improved 184bps YoY to 18.7%, driven by margin discipline and capital efficiency.

Management Guidance

G

Sustained double-digit revenue growth

Management reiterated long-term guidance of sustained double-digit revenue growth, with EBITDA growth slightly ahead.

growth
G

Europe margins to return to mid-teens

Management expects Europe margins to improve to mid-teen levels in coming quarters through operational initiatives.

margins
G

Beauty & cosmetics to grow in high teens

Beauty & cosmetics segment expected to continue growing in high teens, with significant headroom for market share gains.

growth
G

Gradual ROCE improvement

ROCE expected to improve year-on-year through multiple levers, though no specific year-level guidance provided.

other

Key Risks

R

Europe margin recovery may be delayed

Europe margins were impacted by short-term operational issues and adverse mix; recovery to mid-teens may take longer than expected.

medium · management_commentary
R

Commodity price volatility could pressure margins

If polymer prices rise sharply, despite pass-through mechanisms, there is risk of margin compression if negotiations lag.

medium · analyst_question
R

Thailand ramp-up may be gradual

Thailand plant only commercialized in November; scale-up is organic without an anchor customer, so revenue contribution may be slow.

low · analyst_question
R

Customer concentration in oral care

Oral care segment is dominated by a few large customers; any slowdown or inventory correction could impact growth.

medium · data_observation

Notable Quotes

The best is yet to come.
Himanshu Bakshi · MD and Global CEO
Our long-term guidance remains unchanged which is double-digit revenue growth.
Himanshu Bakshi · MD and Global CEO
We are confident of returning to targeted mid-teen margins in the coming quarters.
Himanshu Bakshi · MD and Global CEO